Announce Date | 07/31/2025 |
EPS Normalized Actual | $1.66 (Beat by $0.08) |
EPS GAAP Actual | $1.66 (Beat by $0.08) |
Revenue Actual | $0.966009B |
Revenue Surprise | Beat by $966.009M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.6 |
EPS GAAP Estimate | $1.6 |
Revenue Estimate | $1.0031543B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0 | INF | 0 | 0 | 0 |
Dec 2026 | 5.82 | 22.44 | 5.59302 | 6.03383 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.69 | 0.16 | 0.966009B | 5.79% | -32.73M |
FQ1 2025 (Mar 2025) | 1.19 | -0.1 | 0.887305B | -3.17% | -71.28M |
FQ4 2024 (Dec 2024) | 1.52 | 1.52 | 0.848088B | 1.13% | 848.09M |
FQ3 2024 (Sep 2024) | 1.51 | 1.51 | 0.909291B | 1.79% | 909.29M |
FQ2 2024 (Jun 2024) | 1.36 | 1.36 | 0.910063B | 1.56% | 910.06M |
FQ1 2024 (Mar 2024) | 1.26 | 1.26 | 0.915448B | 6.05% | 915.45M |
FQ4 2023 (Dec 2023) | 0.95 | 0.95 | 0.83848B | 5.08% | 838.48M |
FQ3 2023 (Sep 2023) | 1.28 | 1.28 | 0.892997B | 6.29% | 893M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.6
Consensus Revenue Estimates
1.0031543B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.9491 | -- | 1.92827 | 1.97822 | 1 |
FQ3 2027 (Sep 2027) | 2.1539 | -- | 2.1327 | 2.17723 | 1 |
FQ2 2027 (Jun 2027) | 1.9737 | -- | 1.95428 | 1.99508 | 1 |
FQ1 2027 (Mar 2027) | 1.7096 | -- | 1.69277 | 1.72812 | 1 |
FQ4 2026 (Dec 2026) | 1.64333 | -- | 1.62577 | 1.66789 | 1 |
FQ3 2026 (Sep 2026) | 1.78 | -- | 1.76248 | 1.79928 | 1 |
FQ2 2026 (Jun 2026) | 1.63 | -3.68 | 1.61396 | 1.64766 | 1 |
FQ1 2026 (Mar 2026) | 1.6093 | 26.05 | 1.58144 | 1.63763 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.03B | -- | 1.02B | 1.04B | 2 |
FQ3 2027 (Sep 2027) | 1.06B | -- | 1.05B | 1.07B | 2 |
FQ2 2027 (Jun 2027) | 1.06B | -- | 1.05B | 1.07B | 2 |
FQ1 2027 (Mar 2027) | 1.04B | -- | 1.03B | 1.04B | 2 |
FQ4 2026 (Dec 2026) | 0.95B | -- | 0.94B | 0.96B | 1 |
FQ3 2026 (Sep 2026) | 0.99B | -- | 0.99B | 1B | 1 |
FQ2 2026 (Jun 2026) | 0.99B | 2.73 | 0.99B | 1B | 1 |
FQ1 2026 (Mar 2026) | 0.98B | 9.47 | 0.97B | 0.99B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.53 | 1.69 | 0.16 | 9.47% |
FQ1 2025 (Mar 2025) | 1.29 | 1.19 | -0.1 | -8.4% |
FQ4 2024 (Dec 2024) | 1.52 | 1.52 | 100% | |
FQ3 2024 (Sep 2024) | 1.51 | 1.51 | 100% | |
FQ2 2024 (Jun 2024) | 1.36 | 1.36 | 100% | |
FQ1 2024 (Mar 2024) | 1.26 | 1.26 | 100% | |
FQ4 2023 (Dec 2023) | 0.95 | 0.95 | 100% | |
FQ3 2023 (Sep 2023) | 1.28 | 1.28 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $1B | $0.97B | $-32.73M | -3.39% |
FQ1 2025 (Mar 2025) | $0.96B | $0.89B | $-71.28M | -8.03% |
FQ4 2024 (Dec 2024) | $0B | $0.85B | $848.09M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.91B | $909.29M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.91B | $910.06M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.92B | $915.45M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.84B | $838.48M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.89B | $893M | 100% |